The present invention belongs to the field of organic chemistry, and is related to the preparation method of (4S, 5R)-semiester by the use of 9-epiquininurea
(45, 5R)-semiester represented by general formular (I) is the key intermediate to synthesize (+)-biotin (vitamin Currently, the preparation of the compound includes chiral resolution method, chiral auxiliary method and asymmetric catalysis method. The resolution method was first reported by Gerecke et al. (Helv Chim Acta, 1970, 53, 991) for preparation of racemic CAC monocyclohexanol ester via monoesterification between cycloanhydride (II) and cyclohexanol, then conduct direct enantiomorphous crystallization with pseudoephedrine and resolve to get desired (4S, 5R)-semiester (I). German patent 2058234, Chinese patent 106365, European patent 92194 and Chen Fen-Er et al. (Chemical Journal of Chinese Universities, 2001, 12, 1141) respectively reported preparation of (4S, 5R)-semiester represented by general formular (I) using dehydroabietylamine, substituted chiral diphenyl ethamine and chloromycetin by product (15,25)-threo-1-(p-nitrophenyl)-1,3-propanediol as resolution agent. But those resolution methods have disadvantages of high price, insufficient raw material resource, poor resolution efficiency and uneasy recovery.
Gerecke et al. (Helv Chim Acta, 1970, 53, 991) reported formation of diastereoisomer CAC semi-ester ex cycloanhydride (II) with cholesterin as chiral auxiliary, then via recrystallization and isolation to give (4S, 5R)-semiester (I). European patent 92194 used optically active substituted chiral secondary alcohol and tert-butyl alcohol as chiral auxiliary to prepare (4S, 5R)-semiester (I). But the chiral auxiliaries used in the above-mentioned methods have disadvantages of high price, difficult preparation and uneasy recovery.
European patent 84892, Chen Fen-Er et al. (Advanced Synthesis & Catalysis, 2005, 347, 549) respectively reported the preparation of (4S, 5R)-semiester represented by general formular (I) via stereoselective hydrolysis of meso-diester using pig liver esterase and poly pig liver esterase as catalyst. Chinese patent 1473832, 101157655 respectively described the preparation of (4S, 5R)-semiester represented by general formular (I) via asymmetric alcoholysis of cycloanhydride (II) using chiral amine (1S, 2S)-1-(4-nitrophenyl)-2-N,N-dimethylamino-3-triphenylmethoxy-1-propanol and 9-propargylquinine as catalyst. But those methods have weakness of small production scale, complex operation and strict reaction temperature.
The aim of the said invention is to overcome the disadvantages of existing technology and provide a preparation method of (4S, 5R)-semiester represented by general formular (I) with moderate conditions, high yield and high stereoselectivity.
The said invention conducts enantioselective ring-opening between cycloanhydride (II) and alcohol with presence of 9-epiquininurea to prepare (4S, 5R)-semiester represented by general formular (I) with yield >95% and e.e.>98%. The synthetic route is as follows:
Where in the formula R1 is hydrogen, C1˜C6 alkyl, phenyl, alkyl substituted phenyl or alkoxyl substituted phenyl, Ar is phenyl, alkyl substituted phenyl or alkoxyl substituted phenyl, nitro-substituted phenyl, phenyl halide, thienyl, furyl or naphthyl; R2 is C1˜C6 alkyl, C3˜C6 naphthene, C2˜C6 alkenyl, aralkyl or aralkenyl.
In the said asymmetric monoesterification, catalyst 9-epiquininurea has structure as indicated in Formular A. It enables the performance of reaction at room temperature and preparation of (4S, 5R)-semiester represented by general formular (I) with high yield and high stereoselectivity. Besides, the said chiral catalyst has convenient synthesis, wide availability of raw materials, and can be quantitatively recovered, which is liable for industrialized production.
Where R3 is hydrogen, C1˜C6 alkyl, C2˜C6 alkenyl or C2˜C6 alkynyl; R4 is hydrogen, C1˜C6 alkyl, C2˜C6 alkenyl, C2˜C6 alkynyl, C3˜C6 naphthene, aryl or substituted derivative of any above-mentioned group; R5 is —H or —OR6, R6 is C1˜C6 alkyl, C3˜C6 naphthene, C2˜C6 alkenyl, C2˜C6 acyl, benzyl, benzoyl, cinnamyl or substituted derivative of any above-mentioned group; Z is O, S or Se.
The alcohol used is C1˜C6 alkanol, C3˜C6 naphthenic alcohol, C2˜C6 enol, aralkyl alcohol, arenol or substituted derivative of any above-mentioned alcohol, such as methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, cyclohexanol, ally' alcohol, benzyl alcohol, cinnamyl alcohol etc. for asymmetric monoesterification. Those alcohols are cheap and easily available. The used organic solvent includes halohydrocarbon (e.g. dichloro-methane, chloroform, 1,2-dichloroethane, carbon tetrachloride etc.); aliphatic hydrocarbon (e.g. hexane, heptane, octane, nonane, acetonitrile, ethyl acetate etc.); arene (e.g. benzene, toluene, xylene, nitrobenzene etc.); various haloarene (e.g. chlorobenzene etc.) or ether (e.g. diethyl ether, MTBE, THF or 1,4-dioxane etc.). These solvents are widely available, cheap and easy for recovery. When mol ratio among cycloanhydride (II)/alcohol/chiral catalyst is at 1:1˜10:0.01˜2.2, reaction can be smoothly completed. Control reaction temperature at −15° C.˜50° C., reaction time at 4˜80 hrs for reaction completion.
In the said invention, the preferred chiral catalyst is 9-epiquininurea (A) with vinyl as R3; —OR5 as R4, methyl as R5, S atom as Z. The catalyst has advantages of convenient synthesis, wide raw material resource and easy recovery.
In the said invention, the alcohol used is methanol, which is widely available with low price.
In the said invention, the mol ratio among cycloanhydride (II)/alcohol/chiral catalyst is preferred at 1:3˜10:0.01˜1.1.
In the said invention, the preferred reaction temperature is at 0˜25° C.
In the said invention, the preferred reaction time is at 10˜36 hrs.
In the said invention, the preferred organic solvent is MTBE, which is environmental friendly, widely available with low price.
The said invention has moderate reaction conditions, easy operation, and cheap raw materials with easy availability. What's more, the obtained product has high yield and high stereoselectivity and the catalyst can be quantitatively recovered and recycled. So, the catalyst has low cost and is suitable for industrialized production.
The following examples can better describe the content of the said invention. But the said invention is not limited by those examples.
In a dry flask, transfer cis-1,3-dibenzylimidazoline-2-one-2H-furan[3,4-d]imidazole-2,4,6-trione (33.6 g, 0.10 mol), catalyst A (R3═—CH═CH2, R4═—OR5, R5═CH3, Z═S) (65.34 g, 0.11 mol), MTBE (4L), drop anhydrous methanol (40.4 mL, 1 mol) at 25° C., then continuously stir for 24 hrs. Upon reaction, add 2M hydrochloric acid (400 mL) into remnant, stir for 10 mins, stay still, separate out organic layer and dry with anhydrous sodium sulfate. Filter, recover solvent ex filtrate under vacuum to get white crystal powder I (R1═—H, Ar═—Ph, R2═—CH3, 36 g, 98%) with m.p. 149˜150° C., [α]D22=+2.74° (c 0.20, CHCl3).
IR (KBr): v=2979, 2384, 2281, 1742, 1463, 1229, 1169, 767cm−1.
1H NMR (CDCl3): δ=3.54 (s, 1H, OCH3), 4.00˜4.04 (m, 2H, C6a—H, C3a—H), 4.16˜4.80 (dddd, 4H, 2*CH2C6H5), 7.19˜7.53 (m, 10H, 2*ArH) ppm.
EI-MS: (m/z, %)=368 (M+, 37), 323 (46), 309 (59), 265 (44), 154 (8), 136 (18), 91 (100).
Catalyst recovery: adjust the separated aqueous layer of hydrochloric acid with 20% NaOH solution to pH 14. Filter the isolated white solid, dry to quantitatively recover catalyst.
In a dry flask, transfer cis-1,3-dibenzylimidazoline-2-one-2H-furan[3,4-d]imidazole-2,4,6-trione (33.6 g, 0.10 mol), catalyst A (R3═—CH═CH2, R4═—OR5, R5═CH3, Z═S) (5.94 g, 0.01 mol), 1,4-dioxane (8L), drop propiolic alcohol (58.2 mL, 1 mol) at 25° C., then continuously stir for 24 hrs. Upon reaction, add 2M hydrochloric acid (40 mL) into remnant, stir for 10 mins, stay still, separate out organic layer and dry with anhydrous sodium sulfate. Filter, recover solvent ex filtrate under vacuum to get white crystal powder I (R1═—H, Ar═—Ph, R2═propargyl, 37.2 g, 95%) with m.p. 132.7˜135.8° C., [α]D25=+14.3° (c 1.0, CHCl3).
In a dry flask, transfer cis-1,3-dibenzylimidazoline-2-one-2H-furan[3,4-d]imidazole-2,4,6-trione (33.6 g, 0.10 mol), catalyst A (R3═—CH═CH2, R4═—OR5, R5═CH3, Z═S) (65.34 g, 0.11 mol), 1,4-dioxane (4L), drop anhydrous methanol (40.4 mL, 1.0 mol) at 25° C., then continuously stir for 24 hrs. Upon reaction, add 2M hydrochloric acid (400 mL) into remnant, stir for 10 mins, stay still, separate out organic layer and dry with anhydrous sodium sulfate. Filter, recover solvent ex filtrate under vacuum to get white crystal powder I (R1═—H, Ar═—Ph, R2═—CH3, 35.2 g, 96%) with m.p. 148˜150° C., [α]D22=+2.70° (c 0.20, CHCl3).
In a dry flask, transfer cis-1,3-dibenzylimidazoline-2-one-2H-furan[3,4-d]imidazole-2,4,6-trione (33.6 g, 0.10 mol), catalyst A (R3═—CH2CH3, R4═—OR5, R5═CH3, Z═S) (65.34 g, 0.11 mol), THF (4L), drop anhydrous methanol (40.4 mL, 1.0 mol) at 25° C., then continuously stir for 24 hrs. Upon reaction, add 2M hydrochloric acid (400 mL) into remnant, stir for 10 mins, stay still, separate out organic layer and dry with anhydrous sodium sulfate. Filter, recover solvent ex filtrate under vacuum to get white crystal powder I (R1═—H, R2═—CH3, 35 g, 95%) with m.p. 147˜150° C., [a]D22=+2.70° (c 0.20, CHCl3).
Number | Date | Country | Kind |
---|---|---|---|
200810038584.6 | Jun 2008 | CN | national |
200810042506.3 | Sep 2008 | CN | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/CN09/00627 | 6/5/2009 | WO | 00 | 2/18/2011 |